CoGenesys: the Future of Biopharmaceuticals

CoGenesys is a privately-owned biotechnology company committed to discovering, developing and enhancing next-generation therapeutics through proprietary albumin fusion technology. This broadly applicable technology improves and expands the use of many known and clinically established therapeutic proteins and peptides, and enables the creation of new, more effective medicines. The result? Biopharmaceuticals with longer duration in the bloodstream, reduced dosing and an increased safety profile.
To learn more, click here.

photo: female professional